Renfeng Guo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Renfeng guo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Renfeng Guo Today - Breaking & Trending Today

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Regina Lutz , Renfeng Guo , Nielsc Riedemann , Laurie Doyle , Katja Arnold , Drug Administration , European Medicines Agency , Mc Services , Inflarx Pharmaceuticals Inc , Exchange Commission , Single Ascending Dose , Phasei Study , Chief Scientific Officer , Chief Executive Officer , Inflarx Pharmaceuticals , Ann Arbor ,

InflaRx N : Desired blocking activity (>90%) of C5a-induced neutrophil activation at disease relevant C5a levels 24 hours post administration for doses of 30 mg to 240 mg - Form 6-K -Today at 08:49 am

Desired blocking activity of C5a-induced neutrophil activation at disease relevant C5a levels 24 hours post administration for doses of 30 mg to. ....

United States , Renfeng Guo , Nielsc Riedemann , Laurie Doyle , Katja Arnold , Regina Lutz , Inflarx Pharmaceuticals Inc , Mc Services , European Medicines Agency , Drug Administration , Exchange Commission , Chief Scientific Officer , Chief Executive Officer , Inflarx Pharmaceuticals , Ann Arbor ,

InflaRx (NASDAQ:IFRX) Sees Significant Drop in Short Interest

InflaRx (NASDAQ:IFRX – Get Rating) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 705,400 shares, a decrease of 26.3% from the April 30th total of 956,900 shares. Based on an average daily trading volume, of 2,410,000 shares, the short-interest […] ....

Niels Christoph Riedemann , Nicolas Fulpius , Raymond James , Renfeng Guo , Jpmorgan Chase Co , Kestra Advisory Services , Group One Trading , Virtu Financial , Raymond James Associates , Get Rating , Advisory Services , Inflarx Daily , Nasdaq Ifrx ,

Viveon Health Acquisition (NYSE:VHAQ) vs. InflaRx (NASDAQ:IFRX) Critical Survey

Viveon Health Acquisition (NYSE:VHAQ – Get Rating) and InflaRx (NASDAQ:IFRX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk. Earnings & Valuation This table compares Viveon Health Acquisition […] ....

United States , Nicolas Fulpius , Niels Christoph Riedemann , Renfeng Guo , Viveon Health Acquisition Corp , News Ratings For Viveon Health Acquisition Daily , Viveon Health Acquisition , Get Rating , Given Inflarx , Viveon Health , Health Acquisition , Viveon Health Acquisition Daily , Nyse Vhaq , Stock Comparison , Stock Analysis ,

InflaRx (NASDAQ:IFRX) Short Interest Up 933.4% in April

InflaRx (NASDAQ:IFRX – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 1,890,000 shares, an increase of 933.4% from the March 31st total of 182,900 shares. Based on an average trading volume of 2,300,000 shares, the days-to-cover ratio […] ....

Nicolas Fulpius , Niels Christoph Riedemann , Renfeng Guo , Raymond James , Raymond James Financial Services Advisors Inc , Millennium Management , Invesco Ltd , Renaissance Technologies , Get Rating , Montreal Can , James Financial Services Advisors , Inflarx Daily , Nasdaq Ifrx ,